RecruitingNot ApplicableNCT06263465
Precision Vaginal Microbiome Transplantation in Women With Bacterial Vaginosis
Sponsor
Zhujiang Hospital
Enrollment
120 participants
Start Date
Mar 18, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study was to explore the efficacy and safety of a new vaginal microbiome transplantation technique, using Lactobacillus cispatus from healthy donors as a treatment of bacterial vaginosis.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Lactobacillus cispatus and placebo for people with bacterial vaginosis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 55 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERLactobacillus cispatus
10\^9 cfu,5 days
OTHERplacebo
0 cfu,5 days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06263465
Related Trials
The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study
NCT054341042 locations
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
NCT057538131 location
Prospective Data Bank Creation to Study Vaginal Conditions
NCT018292041 location
Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections
NCT072347861 location
A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis
NCT047717281 location